NEUROCRINE BIOSCIENCES INC Research And Development Expense

Quick Answer

NEUROCRINE BIOSCIENCES INC reported Research And Development Expense of $160.52 million for the year ending 2018.

  • NEUROCRINE BIOSCIENCES INC showed an increase of +31.8% in Research And Development Expense from 2017 to 2018.
  • This data is from NEUROCRINE BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on February 8, 2019.
  • XBRL data for this metric is available from 2009 to 2018 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2009 to 2018), NEUROCRINE BIOSCIENCES INC's Research And Development Expense has grown by 376.0%.
  • Historical annual values: Fiscal year 2018: $160.52 million | Fiscal year 2017: $121.83 million | Fiscal year 2016: $94.29 million | Fiscal year 2015: $81.49 million | Fiscal year 2014: $46.43 million | Fiscal year 2013: $39.25 million | Fiscal year 2012: $37.16 million | Fiscal year 2011: $30.95 million | Fiscal year 2010: $31.15 million | Fiscal year 2009: $33.72 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: